SCHEMBL473537

SCHEMBL473537

Nc1ccc(Oc2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.64
▸ ALDH1A1 P00352 5/20 0.64
▸ TDP1 Q9NUW8 2/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ TSHR P16473 1/20 0.64
▸ MAPT P10636 5/20 0.63
▸ RAB9A P51151 3/20 0.63
▸ NPC1 O15118 2/20 0.63
▸ HPGD P15428 1/20 0.63
▸ MAPK1 P28482 1/20 0.63
▸ MAOB P27338 4/20 0.61
▸ MAOA P21397 2/20 0.54
▸ TEAD4 Q15561 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ POLB P06746 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ MITF O75030 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11438164 0.98 MAOB (0.62) KIF11ALDH1A1TDP1CYP3A4TSHR
SCHEMBL11148692 0.88 CA1 (0.52) KIF11ALDH1A1TSHRMAPTRAB9A
SCHEMBL1685383 0.88 CA1 (0.52) KIF11ALDH1A1TSHRMAPTRAB9A
SCHEMBL9152917 0.86 ALDH1A1 (0.64) KIF11ALDH1A1TDP1CYP3A4TSHR
SCHEMBL29377645 0.85 LTA4H (0.50) KIF11ALDH1A1TSHRMAPTRAB9A
SCHEMBL25434828 0.85 ALDH1A1 (0.56) KIF11ALDH1A1TDP1CYP3A4TSHR
SCHEMBL1284319 0.85 ALDH1A1 (0.56) KIF11ALDH1A1TDP1CYP3A4TSHR
SCHEMBL10302 0.85 KIF11 (0.84) KIF11ALDH1A1TDP1TSHRMAPT
SCHEMBL8152515 0.85 ALDH1A1 (0.56) KIF11ALDH1A1TDP1CYP3A4TSHR
SCHEMBL27948267 0.85 KIF11 (0.84) KIF11ALDH1A1TDP1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496578-A2 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME University of Notre Dame du Lac (US) 2012-09-12 — — EP claimed
US-20120220457-A1 IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME DOW AGROSCIENCES LLC (US) 2012-08-30 — — US claimed
WO-2011057145-A2 IMIDAZO[1,2-A] PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME UNIVERSITY OF NOTRE DAME DU LAC (US) 2011-05-12 — — WO claimed
EP-3797991-B1 PREPREG AND PRODUCTION METHOD THEREFOR, SLIT TAPE PREPREG, CARBON FIBER-REINFORCED COMPOSITE MATERIAL TORAY INDUSTRIES (JP) 2025-10-29 — — EP disclosed
US-12448510-B2 Prepreg, method for producing same, and slit tape prepreg TORAY INDUSTRIES, INC. (JP) 2025-10-21 — — US disclosed
EP-3995536-B1 PREPREG AND FIBER-REINFORCED COMPOSITE MATERIAL TORAY INDUSTRIES (JP) 2025-06-18 — — EP disclosed
CN-113164495-B Covalent targeting of E3 ligases 加利福尼亚大学董事会 2025-04-22 — — CN disclosed
US-20250120982-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-04-17 — — US disclosed
US-20250051335-A1 TAU-TUBULIN KINASE (TTBK) INHIBITOR COMPOUNDS CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2025-02-13 — — US disclosed
US-12161648-B2 Covalent targeting of E3 ligases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-12-10 — — US disclosed
CN-118852135-A N-acyl sulfonamide compound, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-10-29 — — CN disclosed
EP-0231512-A1 Cyclic malonylphosphonic acid diamides, process for their preparation and their use for pestcontrol BAYER AG (DE) 1987-08-12 — — EP disclosed
EP-0228894-A2 Pesticidal compounds THE WELLCOME FOUNDATION LIMITED (GB) 1987-07-15 — — EP disclosed
EP-0216105-A1 Diazaphosphorines, process for their preparation and their use as pesticide BAYER AG (DE) 1987-04-01 — — EP disclosed
EP-0132680-B1 SUBSTITUTED FURAZANS BAYER AG (DE) 1987-01-28 — — EP disclosed
EP-0156198-A2 Process for the preparation of isocyanates BAYER AG (DE) 1985-10-02 — — EP disclosed
EP-0132680-A1 Substituted furazans BAYER AG (DE) 1985-02-13 — — EP disclosed
EP-0105029-A2 Barbituric-acid derivatives as anthelmintica CIBA-GEIGY AG (CH) 1984-04-04 — — EP disclosed
EP-0012435-A2 Isoxazole derivatives, process for their preparation, medicines containing them and intermediates required in this process HOECHST AKTIENGESELLSCHAFT (DE) 1980-06-25 — — EP disclosed
US-4080193-A (Trifluoromet hylphenoxy)-phenylurea compounds and herbicidal compositions BAYER AKTIENGESELLSCHAFT (DT) 1978-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220457-A1 IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME RIF1, PYCR1, PNMT KIF11 4408/4885ALDH1A1 1244/4885TDP1 1060/4885
US-12161648-B2 Covalent targeting of E3 ligases RNF114, RNF4, RNF168 KIF11 1052/4885ALDH1A1 2969/4885TDP1 1403/4885
US-20250051335-A1 TAU-TUBULIN KINASE (TTBK) INHIBITOR COMPOUNDS TTBK1, TTBK2, MAPT KIF11 468/4885ALDH1A1 3733/4885TDP1 78/4885
US-20250120982-A1 COVALENT TARGETING OF E3 LIGASES STUB1, XIAP, RBX1 KIF11 2190/4885ALDH1A1 2485/4885TDP1 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback